Gates Foundation, Wellcome to fund $550M PhIII study of GSK’s tuberculosis vaccine

Two nonprofit organizations are teaming up for a giant study of an experimental vaccine designed to protect against the world’s deadliest infectious disease — and it’s not Covid-19.

The Bill and Melinda Gates Foundation and Wellcome are committing $550 million to fund a Phase III clinical trial of…
Click here to view original post